·2,447,543篇论文数据,部分数据来源于NoteExpress
The worst performance came from Pain Therapeutics, after the U.S. Food and Drug Administration rejected the narcotic pain reliever it was developing with Pfizer.
FORBES: Biotech Busts And Breakthroughs For June 2011
应用推荐
模块上移
模块下移
不移动